Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry

Acetylsalicylic acid (ASA), also known as aspirin, appears to be ineffective in inhibiting platelet aggregation in 20–30% of patients. Light transmission aggregometry (LTA) is a gold standard platelet function assay. In this pilot study, we used LTA to personalize ASA therapy ex vivo in atherosclero...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Hamzah, Gallant, Reid C., Zamzam, Abdelrahman, Jain, Shubha, Afxentiou, Sherri, Syed, Muzammil, Kroezen, Zachary, Shanmuganathan, Meera, Britz-McKibbin, Philip, Rand, Margaret L., Ni, Heyu, Al-Omran, Mohammed, Qadura, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693608/
https://www.ncbi.nlm.nih.gov/pubmed/33114560
http://dx.doi.org/10.3390/diagnostics10110871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693608/
https://www.ncbi.nlm.nih.gov/pubmed/33114560
http://dx.doi.org/10.3390/diagnostics10110871

Ejemplares similares